Literature DB >> 46911

Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development.

S Yachnin.   

Abstract

Fetuin, the bovine alpha-fetoprotein, contains glycopeptide sequences similar to those found on red cells. As a result, it is capable of strong physical interaction with the phytohemagglutinin isomitogens (H-PHAP) which possess two or more R (red cell binding) subunits as part of their tetrameric structures. Fetuin shows little or no interaction with L-PHAP, a phytohemagglutinin made up of four L subunits which also lack red cell affinity. Despite these differences fetuin is able to inhibit both H- and L-PHAP-induced lymphocyte transformation and is also capable of inhibiting the mitogenic effects of pokeweed mitogen, concanavalin A, antithymocyte antiserum, and the one-way mixed lymphocyte culture. In the case of L-PHAP, the inhibitory effect of fetuin is proportional to the intensity of the mitogenic stimulus. The inhibitory effects of fetuin upon lymphocyte transformation may result from perturbation or "blindfolding" of the cell membrane in a manner analogous to other immunosuppressive serum alpha-globulins. Alpha-Fetoproteins may play an immunoregulatory role during fetal development.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46911      PMCID: PMC2190513          DOI: 10.1084/jem.141.1.242

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Serum alpha-fetoprotein, albumin, and gamma-G-globulin in the human conceptus.

Authors:  D Gitlin; M Boesman
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

2.  Prolongation of allograft survival by an alpha globulin isolated from normal blood.

Authors:  J A Mannick; K Schmid
Journal:  Transplantation       Date:  1967-07       Impact factor: 4.939

3.  Immunoregulatory d-globulin: failure to inhibit antibody response when administered after antigen exposure.

Authors:  A H Glasgow; J O Menzoian; S R Cooperband; R B Nimberg; K Schmid; J A Mannick
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

4.  The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro.

Authors:  S R Cooperband; A M Badger; R C Davis; K Schmid; J A Mannick
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

5.  Inhibition of phytohemagglutinin-induced lymphocyte transformation by globulins; lack of correlation with phytohemagglutinin precipitation by serum proteins.

Authors:  S Yachnin
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

6.  Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA).

Authors:  S R Cooperband; R C Davis; K Schmid; J A Mannick
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

7.  Immunological studies of phytohaemagglutinin. I. Reaction between phytohaemagglutinin and normal sera.

Authors:  J H Morse
Journal:  Immunology       Date:  1968-05       Impact factor: 7.397

8.  Transformation of human lymphocytes: inhibition by homologous alpha globulin.

Authors:  S R Cooperband; H Bondevik; K Schmid; J A Mannick
Journal:  Science       Date:  1968-03-15       Impact factor: 47.728

9.  Concanavalin A reaction with human normal immunoglobulin G and myeloma immunoglobulin G.

Authors:  M A Leon
Journal:  Science       Date:  1967-12-08       Impact factor: 47.728

10.  The rapid induction by phytohemagglutinin of increased alpha-aminoisobutyric acid uptake by lymphocytes.

Authors:  J Mendelsohn; A Skinner; S Kornfeld
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

View more
  11 in total

1.  Interactions of alpha1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness.

Authors:  K M Chiu; R F Mortensen; A P Osmand; H Gewurz
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

2.  Immunologic and genetic factors influencing reproduction. A review.

Authors:  T J Gill; C F Repetti
Journal:  Am J Pathol       Date:  1979-05       Impact factor: 4.307

3.  A fetuin-related glycoprotein (alpha 2HS) in human embryonic and fetal development.

Authors:  K M Dziegielewska; K Møllgård; M L Reynolds; N R Saunders
Journal:  Cell Tissue Res       Date:  1987-04       Impact factor: 5.249

4.  Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP): studies on the mode of HAFP action and the role of HAFP polymorphism.

Authors:  E P Lester; J B Miller; J M Baron; S Yachnin
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

5.  Suppressor thymus-derived lymphocytes in fungal infection.

Authors:  J D Stobo; S Paul; R E Van Scoy; P E Hermans
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

6.  Specific interaction of human Tamm-Horsfall gylcoprotein with leucoagglutinin, a lectin from Phaseolus vulgaris (red kidney bean).

Authors:  F Serafini-Cessi; C Franceschi; S Sperti
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

7.  Neutrophils are required for the DNA synthetic response of human lymphocytes to mevalonic acid: evidence suggesting that a nonsterol product of mevalonate is involved.

Authors:  R A Larson; J Chung; A M Scanu; S Yachnin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Rosette formation between human lymphocytes and sheep erythrocytes. Inhibition of rosette formation by specific glycopeptides.

Authors:  D H Boldt; J P Armstrong
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

9.  Cytochalasin B is a potent mitogen for chronic lymphocytic leukemia cells in vitro.

Authors:  R A Larson; S Yachnin
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

10.  Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP); comparison of foetal and hepatoma HAFP and kinetic studies in vitro immunosuppression.

Authors:  S Yachnin; E Lester
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.